Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-01-22 @ 7:24 AM
Study NCT ID:
NCT04990557
Status:
UNKNOWN
Last Update Posted:
2021-08-16
First Post:
2021-08-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients
Sponsor:
Mahmoud Ramadan mohamed Elkazzaz
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Novel Treatment for Covid-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None